Medical specialists from France tagged as investigators in clinical trials studying Hepatitis B

Total 23 results

Anne GERVAIS
Seen in:
- Paris, Bichat-Claude Bernard Hospital
Trials:
- NCT04166266 (Principal Investigator)
Conditions:
- Hepatitis D, Chronic;
- Hepatitis B, Chronic
Caroline Lascoux-Combe
Seen in:
- Paris, Hôpital Saint- Louis - SMIT
- Paris, Saint Louis Hospital
Trials:
- NCT04166266 (Principal Investigator)
- NCT05300035 (Principal Investigator)
Conditions:
Dulce ALFAIATE
Seen in:
- Lyon, Croix Rousse Hospital
Trials:
- NCT04166266 (Principal Investigator)
Conditions:
- Hepatitis D, Chronic;
- Hepatitis B, Chronic
Fabien Zoulim
Seen in:
- Lyon Cedex 04, GSK Investigational Site
- Lyon cedex 04, GSK Investigational Site
- Lyon, Hepatology Department - Hospices Civils de Lyon
- Lyon, Hôpital de La Croix Rousse
Trials:
- NCT05630820 (Principal Investigator)
- NCT04166266 (Principal Investigator)
- NCT05276297 (Principal Investigator)
- NCT03866187 (Principal Investigator)
- NCT06047093 (Principal Investigator)
Conditions:
François Habersetzer
Seen in:
- Strasbourg cedex, GSK Investigational Site
Trials:
- NCT05276297 (Principal Investigator)
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
François RAFFI
Seen in:
- Nantes, CHU Nantes - Hôtel-Dieu
- Nantes, CHU de Nantes
- Nantes, GSK Investigational Site
- Nantes, Hôtel-Dieu Hospital
Trials:
- NCT04885452 (Principal Investigator)
- NCT03696160 (Principal Investigator)
- NCT04166266 (Principal Investigator)
- NCT02898987 (Principal Investigator)
- NCT03795376 (Principal Investigator)
- NCT06039579 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection;
- HIV/AIDS;
- Hepatitis D, Chronic;
- Hepatitis B, Chronic;
- HIV;
- HIV Prevention;
- HIV Infections
Ghassan Riachi
Seen in:
- Rouen cedex, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Isabelle FOUCHARD
Seen in:
- Angers, CHU of Angers
Trials:
- NCT04166266 (Principal Investigator)
Conditions:
- Hepatitis D, Chronic;
- Hepatitis B, Chronic
Isabelle Rosa
Seen in:
- Créteil Cedex, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Julie CHAS
Seen in:
- Paris, Hopital Tenon
Trials:
- NCT04166266 (Principal Investigator)
Conditions:
- Hepatitis D, Chronic;
- Hepatitis B, Chronic
Karine Lacombe
Seen in:
- Paris, GSK Investigational Site
- Paris, Hopital Saint Antoine
- Paris, Hôpital Saint-Antoine - SMIT
- Paris, Saint Antoine Hospital
- Paris, Saint-Antoine Hospital
Trials:
- NCT04885452 (Principal Investigator)
- NCT03696160 (Principal Investigator)
- NCT04166266 (Principal Investigator)
- NCT04133012 (Principal Investigator)
- NCT05300035 (Principal Investigator)
- NCT05222945 (Principal Investigator)
- NCT05979311 (Principal Investigator)
- NCT06039579 (Principal Investigator)
Conditions:
- Covid19;
- SARS-CoV Infection;
- HIV/AIDS;
- Hepatitis D, Chronic;
- Hepatitis B, Chronic;
- HIV-1 Infection;
- HIV/AIDS and Infections;
- HIV-1-infection;
- HIV Infections;
- HIV
Laurent Alric
Seen in:
- Toulouse cedex 9, GSK Investigational Site
- Toulouse, CHU de Toulouse
- Toulouse, Hopital Rangueil
Trials:
- NCT05641142 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT04166266 (Principal Investigator)
Conditions:
Lawrence Serfaty
Seen in:
- Strasbourg Cedex, GSK Investigational Site
- Strasbourg, GSK Investigational Site
Trials:
- NCT05583344 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease;
- Hepatitis B
Marc-Antoine VALANTIN
Seen in:
- Paris, Pitie-Salpêtrière Hospital
Trials:
- NCT04166266 (Principal Investigator)
Conditions:
- Hepatitis D, Chronic;
- Hepatitis B, Chronic
Marie Noelle Hilleret
Seen in:
- Grenoble cedex 9, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Patrick MIAILHES, MD, PhD
Seen in:
- Lyon, Hôpital de la Croix-Rousse - Service de maladies infectieuses et tropicales
Trials:
- NCT03825458 (Principal Investigator)
Conditions:
- Hepatitis B
Pr Thomas Jouve
Seen in:
- Aura, Grenoble, Grenoble University Hospital
Trials:
- NCT06307808 (Principal Investigator)
Conditions:
Stanislas Pol
Seen in:
- Paris, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Tarik Asselah
Seen in:
- Clichy Cedex, GSK Investigational Site
- Clichy, Beaujon Hospital
- Clichy, GSK Investigational Site
Trials:
- NCT05630807 (Principal Investigator)
- NCT04166266 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions:
Veronique Loustaud Ratti
Seen in:
- Limoges cedex, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Vincent Leroy
Seen in:
- Créteil cedex, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT05630820 (Principal Investigator)
Conditions:
Vlad Ratziu
Seen in:
- Paris Cedex 13, GSK Investigational Site
- Paris, Hôpital Pitié-Salpêtrière - IM2A
- Paris, Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière
Trials:
- NCT04166773 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
- NCT05479721 (Principal Investigator)
Conditions:

Clinical Trials on Hepatitis B

The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Gilead Sciences

Not yet recruiting

Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China (GATE)

Chronic Hepatitis b

China
Ain Shams University

Completed

Resistance to Lamivudine in HBV Egyptian Patients

Chronic Hepatitis B Virus Treatment

Egypt
National Taiwan University Hospital
Chiayi Christian Hospital; E-DA Hospital; Taipei City Hospital; Taipei Tzu Chi... and other collaborators

Recruiting

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue (CHANGE)

Chronic Hepatitis b | Hepatitis B Reactivation

Taiwan
Mahidol University

Unknown

HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine

Thailand
Nanfang Hospital of Southern Medical University

Recruiting

Biomarkers Guided Stopping NAs Treatment

Chronic Hepatitis b

China
IlDong Pharmaceutical Co Ltd

Recruiting

A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

Chronic Hepatitis b

Korea, Republic of
Antios Therapeutics, Inc

Terminated

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

Chronic Hepatitis b

United States
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Unknown

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Chronic Hepatitis b | Cirrhosis Due to Hepatitis B

China
Tongji Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (Neptune)

Chronic Hepatitis b

Medical specialists from France tagged as investigators in clinical trials studying Hepatitis B

Clinical Trials on Hepatitis B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations